Pulsehaler
Mar 2021
134d
Respinova, Ltd. has submitted 1 FDA 510(k) premarket notifications since 2021, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Spirometer, Therapeutic (incentive) . Use the specialty filter in the sidebar to narrow results.